Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D315-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
filingDate |
1993-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cbb35f9b3689d4fe058b9953ab3893c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38332998cd8ffc52ee2d19ce397bd4e3 |
publicationDate |
1996-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0727941-A1 |
titleOfInvention |
Methods of achieving antitumor activity using 16-membered-macrolide-type compounds |
abstract |
Inhibition of renal cancer, melanoma, colon cancer, lung cancer and leukemia cells by administration of compounds from the bafilomycin and hygrolidin groups of compounds. |
priorityDate |
1992-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |